166 related articles for article (PubMed ID: 16799039)
1. Macrophages are vital in spontaneous intraocular tumor eradication.
Boonman ZF; Schurmans LR; van Rooijen N; Melief CJ; Toes RE; Jager MJ
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2959-65. PubMed ID: 16799039
[TBL] [Abstract][Full Text] [Related]
2. Role of TRAIL and IFN-gamma in CD4+ T cell-dependent tumor rejection in the anterior chamber of the eye.
Wang S; Boonman ZF; Li HC; He Y; Jager MJ; Toes RE; Niederkorn JY
J Immunol; 2003 Sep; 171(6):2789-96. PubMed ID: 12960299
[TBL] [Abstract][Full Text] [Related]
3. Successful immunotherapy of an intraocular tumor in mice.
Schurmans LR; den Boer AT; Diehl L; van der Voort EI; Kast WM; Melief CJ; Toes RE; Jager MJ
Cancer Res; 1999 Oct; 59(20):5250-4. PubMed ID: 10537305
[TBL] [Abstract][Full Text] [Related]
4. Ocular immune privilege is circumvented by CD4+ T cells, leading to the rejection of intraocular tumors in an IFN-{gamma}-dependent manner.
Dace DS; Chen PW; Alizadeh H; Niederkorn JY
J Leukoc Biol; 2007 Feb; 81(2):421-9. PubMed ID: 17077163
[TBL] [Abstract][Full Text] [Related]
5. A novel treatment for ocular tumors using membrane FasL vesicles to activate innate immunity and terminate immune privilege.
Gregory MS; Koh S; Huang E; Saff RR; Marshak-Rothstein A; Mukai S; Ksander BR
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2495-502. PubMed ID: 15980241
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T cells circumvent immune privilege in the eye and mediate intraocular tumor rejection by a TNF-alpha-dependent mechanism.
Dace DS; Chen PW; Niederkorn JY
J Immunol; 2007 May; 178(10):6115-22. PubMed ID: 17475837
[TBL] [Abstract][Full Text] [Related]
7. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection.
Cheng H; Tumpey TM; Staats HF; van Rooijen N; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1402-9. PubMed ID: 10798656
[TBL] [Abstract][Full Text] [Related]
8. Termination of systemic immunity in the presence of intraocular tumors: influence of ocular immune privilege on tumor vaccines.
Chen PW; Ksander BR
Curr Eye Res; 2006 Jan; 31(1):43-55. PubMed ID: 16421019
[TBL] [Abstract][Full Text] [Related]
9. Complete elimination ('cure') of progressively growing intraocular tumors by local injection of tumor-specific CD8+ T lymphocytes.
Miki S; Ksander B; Streilein JW
Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3622-34. PubMed ID: 8258521
[TBL] [Abstract][Full Text] [Related]
10. In aged mice, outgrowth of intraocular melanoma depends on proangiogenic M2-type macrophages.
Ly LV; Baghat A; Versluis M; Jordanova ES; Luyten GP; van Rooijen N; van Hall T; van der Velden PA; Jager MJ
J Immunol; 2010 Sep; 185(6):3481-8. PubMed ID: 20713886
[TBL] [Abstract][Full Text] [Related]
11. CD4+ T-cell-dependent tumour rejection in an immune-privileged environment requires macrophages.
Dace DS; Chen PW; Niederkorn JY
Immunology; 2008 Mar; 123(3):367-77. PubMed ID: 17944931
[TBL] [Abstract][Full Text] [Related]
12. Analysis of cytotoxic T cell responses to intracameral allogeneic tumors.
Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1989 Feb; 30(2):323-9. PubMed ID: 2492486
[TBL] [Abstract][Full Text] [Related]
13. The role of macrophages in the pathogenesis of HSV-1 induced chorioretinitis in BALB/c mice.
Berra A; Rodriguez A; Heiligenhaus A; Pazos B; Van Rooijen N; Foster CS
Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):2990-8. PubMed ID: 7911460
[TBL] [Abstract][Full Text] [Related]
14. Adoptive transfer of immunity to intraocular tumors in mice.
Niederkorn JY; Streilein JW
Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):336-42. PubMed ID: 6421767
[TBL] [Abstract][Full Text] [Related]
15. Requirement of CD80+ costimulation for rejection of ocular tumors and termination of immune privilege.
Chen PW; Uno T; Ksander BR
Exp Eye Res; 2006 Sep; 83(3):574-83. PubMed ID: 16643898
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic analysis of intraocular allogeneic tumors in mice.
Luckenbach MW; Streilein JW; Niederkorn JY
Invest Ophthalmol Vis Sci; 1985 Oct; 26(10):1368-76. PubMed ID: 3930419
[TBL] [Abstract][Full Text] [Related]
17. Rejection of intraocular tumors by CD4(+) T cells without induction of phthisis.
Schurmans LR; Diehl L; den Boer AT; Sutmuller RP; Boonman ZF; Medema JP; van der Voort EI; Laman J; Melief CJ; Jager MJ; Toes RE
J Immunol; 2001 Nov; 167(10):5832-7. PubMed ID: 11698457
[TBL] [Abstract][Full Text] [Related]
18. Potential role of macrophages in experimental keratomycosis.
Hu J; Wang Y; Xie L
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2087-94. PubMed ID: 19074808
[TBL] [Abstract][Full Text] [Related]
19. Effect of macrophage depletion on immune effector mechanisms during corneal allograft rejection in rats.
Slegers TP; Torres PF; Broersma L; van Rooijen N; van Rij G; van der Gaag R
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2239-47. PubMed ID: 10892868
[TBL] [Abstract][Full Text] [Related]
20. Impaired th1/tc1 cytokine production of tumor-infiltrating lymphocytes in a model of primary intraocular B-cell lymphoma.
Touitou V; Daussy C; Bodaghi B; Camelo S; de Kozak Y; Lehoang P; Naud MC; Varin A; Thillaye-Goldenberg B; Merle-Béral H; Fridman WH; Sautès-Fridman C; Fisson S
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3223-9. PubMed ID: 17591892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
